Stakeholders: CMS' Revamped Drug Guidance Is Good For Beneficiaries, Hospice Providers

By Michelle M. Stein / July 18, 2014 at 6:58 PM
Beneficiary advocates and hospice providers applaud CMS' overhaul of controversial drug prior-authorization guidelines for hospice beneficiaries, unveiled Friday (July 18), as a move that should help reduce access problems for terminally ill beneficiaries and providers. The agency decided to limit the scope of the prior-authorization policy after the guidelines faced strong pushback from stakeholders and lawmakers. The original policy , which went into effect in May, instructed Part D plans to put all hospice beneficiaries' drugs under prior authorization --...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.